[Thrombocyte aggregation inhibitors. A new class of active substances].
D000262:Adenylyl Cyclases / Q000378:metabolism; D000818:Animals; D000925:Anticoagulants / Q000494:pharmacology*; D001792:Blood Platelets / Q000502:physiology; D002462:Cell Membrane / Q000187:drug effects; D004537:Eicosanoic Acids / Q000494:pharmacology; D004789:Enzyme Activation / Q000187:drug effects; D011464:Epoprostenol / Q000096:biosynthesis; D006801:Humans; D010726:Phosphodiesterase Inhibitors; D010972:Platelet Activating Factor / Q000502:physiology; D010974:Platelet Aggregation / Q000187:drug effects*; D013928:Thromboxane A2 / Q000096:biosynthesis
D000925:Anticoagulants; D004537:Eicosanoic Acids; D010726:Phosphodiesterase Inhibitors; D010972:Platelet Activating Factor; D013928:Thromboxane A2; D011464:Epoprostenol; D000262:Adenylyl Cyclases
Thrombozytenaggregationshemmer--eine neue Wirkstoffklasse. Teil 1.